PMID- 10075741 OWN - NLM STAT- MEDLINE DCOM- 19990415 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 274 IP - 12 DP - 1999 Mar 19 TI - c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. PG - 8335-43 AB - Accumulating evidence indicates that interactions between the epidermal growth factor receptor (EGFR) and the nonreceptor tyrosine kinase c-Src may contribute to an aggressive phenotype in multiple human tumors. Previous work from our laboratory demonstrated that murine fibroblasts which overexpress both these tyrosine kinases display synergistic increases in DNA synthesis, soft agar growth, and tumor formation in nude mice, and increased phosphorylation of the receptor substrates Shc and phospholipase gamma as compared with single overexpressors. These parameters correlated with the ability of c-Src and EGFR to form an EGF-dependent heterocomplex in vivo. Here we provide evidence that association between c-Src and EGFR can occur directly, as shown by receptor overlay experiments, and that it results in the appearance of two novel tyrosine phosphorylations on the receptor that are seen both in vitro and in vivo following EGF stimulation. Edman degradation analyses and co-migration of synthetic peptides with EGFR-derived tryptic phosphopeptides identify these sites as Tyr845 and Tyr1101. Tyr1101 lies within the carboxyl-terminal region of the EGFR among sites of receptor autophosphorylation, while Tyr845 resides in the catalytic domain, in a position analogous to Tyr416 of c-Src. Phosphorylation of Tyr416 and homologous residues in other tyrosine kinase receptors has been shown to be required for or to increase catalytic activity, suggesting that c-Src can influence EGFR activity by mediating phosphorylation of Tyr845. Indeed, EGF-induced phosphorylation of Tyr845 was increased in MDA468 human breast cancer cells engineered to overexpress c-Src as compared with parental MDA 468 cells. Furthermore, transient expression of a Y845F variant EGFR in murine fibroblasts resulted in an ablation of EGF-induced DNA synthesis to nonstimulated levels. Together, these data support the hypothesis that c-Src-mediated phosphorylation of EGFR Tyr845 is involved in regulation of receptor function, as well as in tumor progression. FAU - Biscardi, J S AU - Biscardi JS AD - Department of Microbiology and Cancer Center, Box 441, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA. FAU - Maa, M C AU - Maa MC FAU - Tice, D A AU - Tice DA FAU - Cox, M E AU - Cox ME FAU - Leu, T H AU - Leu TH FAU - Parsons, S J AU - Parsons SJ LA - eng GR - CA3948/CA/NCI NIH HHS/United States GR - CA71449/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 42HK56048U (Tyrosine) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.2 (CSK Tyrosine-Protein Kinase) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.10.23 (CSK protein, human) SB - IM MH - Amino Acid Sequence MH - Animals MH - CSK Tyrosine-Protein Kinase MH - Cell Line MH - ErbB Receptors/*metabolism MH - Humans MH - Mice MH - Mice, Inbred C3H MH - Mitosis MH - Molecular Sequence Data MH - Peptide Mapping MH - Phosphorylation MH - Protein Binding MH - Protein-Tyrosine Kinases/*metabolism MH - Structure-Activity Relationship MH - Tumor Cells, Cultured MH - Tyrosine/*metabolism MH - src Homology Domains MH - src-Family Kinases EDAT- 1999/03/13 00:00 MHDA- 1999/03/13 00:01 CRDT- 1999/03/13 00:00 PHST- 1999/03/13 00:00 [pubmed] PHST- 1999/03/13 00:01 [medline] PHST- 1999/03/13 00:00 [entrez] AID - 10.1074/jbc.274.12.8335 [doi] AID - S0021-9258(19)87544-0 [pii] PST - ppublish SO - J Biol Chem. 1999 Mar 19;274(12):8335-43. doi: 10.1074/jbc.274.12.8335.